Class IIITerminatedD-0655-2021
Drug recall · July 21, 2021
LEUKINE recall
Why: FAILED STABILITY SPECIFICATION: Out-of-specification (OOS) result observed for Leukine (sargramostim) at the 27-month stability timepoint.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
LEUKINE (Sargramostim) for Injection, 250 mcg/ vial, 5mL vials, 5 (250 mcg vials) per box, Rx only, Mfd by Partner Therapeutics, Inc. Lexington, MA 02421, NDC 71837-5843-5
- Lots / codes
Lot #: E8023E, exp. date 11/30/2022
- Quantity
- 32,260 vials
- Company
- Partner Therapeutics Inc, Lynnwood, WA
- Distribution
- Product was distributed to one government account (ASPR)
- Initiated
- June 23, 2021 · Voluntary: Firm initiated
- Classified
- July 13, 2021
- Reported
- July 21, 2021
- Ended
- February 7, 2023
- How notified
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.